Zeng, Ke-Wu <br/><br/>
Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.  [electronic resource] 

 -  European journal of pharmacology  Aug 2013 
 - 261-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2013.04.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Hepatocellular--blood supply<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Enzyme Activation--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Liver Neoplasms--blood supply<br/>MAP Kinase Signaling System--drug effects<br/>Matrix Metalloproteinase 2--metabolism<br/>Matrix Metalloproteinase 9--metabolism<br/>Mice<br/>Mice, Nude<br/>Neoplasm Invasiveness<br/>Neovascularization, Pathologic--drug therapy<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Saponins--pharmacology<br/>TOR Serine-Threonine Kinases--metabolism<br/>Vascular Endothelial Growth Factor A--pharmacology<br/>Vascular Endothelial Growth Factor Receptor-2--metabolism<br/>Xenograft Model Antitumor Assays<br/>p38 Mitogen-Activated Protein Kinases--metabolism